Side-by-side comparisons of the most commonly researched peptide pairs — covering mechanisms, dosing, efficacy, and which compound is right for your research goals.
Choosing between two peptides is rarely straightforward. Sermorelin and CJC-1295 both stimulate growth hormone release, but through different half-lives and receptor kinetics. Semaglutide and tirzepatide both target the GLP-1 pathway, but tirzepatide's dual GIP agonism produces meaningfully different clinical outcomes. The mechanism-level differences that matter most are often the ones that don't appear in marketing copy.
Each comparison guide on this page starts at the receptor level — how each compound binds, what downstream signaling it activates, and where the two pathways diverge. From there we layer in clinical evidence, dosing considerations, and the research contexts where one compound has a clear advantage over the other. Evidence is rated by study design throughout: randomized controlled trial data is weighted differently from animal model data.
These guides are written for researchers who want to understand the tradeoffs, not just pick a winner. If you already know which compound you're researching, the full compound profiles are in the Compound Library. If you want to compare more than two compounds at once, the Full Comparison Chart covers all 40 compounds side-by-side.
GH secretagogue comparison — mechanism, dosing, and stacking
Triple vs dual agonist — fat loss, side effects, and clinical data
Copper peptide vs lipopeptide for skin anti-aging
Tissue repair vs immune modulation — which is right for you?
Mitochondrial peptide vs coenzyme for metabolic optimization
Cardiolipin stabilization vs AMPK activation — two distinct mitochondrial mechanisms compared
Modified vs natural GHRH analog — potency and physiological effects
GHRH analogue comparison — half-life, FDA approval, and visceral fat evidence
Three-way GHRH analogue comparison — pulsatile vs sustained GH, FDA status, and fat loss evidence
Three-way GHRP comparison — GH selectivity, cortisol co-stimulation, appetite effects, and stacking protocols
GHRH analogues vs GHRP — dual-pathway synergy, stacking protocols, and which combination produces the most GH
GHRP vs GHRH analogue — GH pulse mechanism, visceral fat evidence, FDA approval status, and stacking protocols
GLP-1 vs dual agonist — fat loss, safety, and clinical outcomes
Telomere maintenance vs tissue remodeling for anti-aging
Telomere/epigenetic axis vs AMPK/metabolic axis — two complementary longevity mechanisms
Mitochondrial energy coenzyme vs master antioxidant — when to use each and how to stack them
Nootropic vs anxiolytic — BDNF/dopamine focus vs GABA-A anxiety reduction
Adaptive T-cell immunity vs innate antimicrobial defense — two complementary immune peptides compared
Tissue repair & gut-immune axis vs innate antimicrobial defense — mechanisms, wound healing, and stacking guide
Three-way comparison: localized repair, systemic repair, and antimicrobial defense — the most complete recovery stack
Route of administration comparison — bioavailability, onset, condition-specific selection, and the GI vs systemic debate
Vascularization vs Wnt/β-catenin reactivation — two complementary mechanisms for hair loss, with decision matrix for AGA, TE, and general thinning
The GLP-1 peptide family spans three generations — semaglutide, tirzepatide, and retatrutide — each with distinct receptor profiles and clinical outcomes.
Three-way GLP comparison: efficacy, side effects, cost
Same molecule, different formulations — what changes?
Dual vs single agonist head-to-head
Next-gen triple agonist vs first-gen GLP-1
Ozempic vs Wegovy — same drug, different doses
Mounjaro vs Wegovy for weight management
Every comparison starts with receptor-level mechanisms. Understanding how each compound works at the molecular level reveals why they may complement or duplicate each other.
We rate evidence by study design: RCT > cohort > animal model > in vitro. Knowing the evidence tier prevents over-extrapolating from preliminary data.
Peptide comparisons are only meaningful within a specific research context — recovery, fat loss, anti-aging, or cognitive enhancement. Each guide frames comparisons by goal.
Compare all 40 compounds side-by-side across category, mechanism, half-life, and evidence level.